ATE338759T1 - 2-(aminomethyl)tetrahydro-9-oxa-1,3- diazacyclopentaca)naphthalinylderivate mit antipsychotischer wirkung - Google Patents

2-(aminomethyl)tetrahydro-9-oxa-1,3- diazacyclopentaca)naphthalinylderivate mit antipsychotischer wirkung

Info

Publication number
ATE338759T1
ATE338759T1 AT02761135T AT02761135T ATE338759T1 AT E338759 T1 ATE338759 T1 AT E338759T1 AT 02761135 T AT02761135 T AT 02761135T AT 02761135 T AT02761135 T AT 02761135T AT E338759 T1 ATE338759 T1 AT E338759T1
Authority
AT
Austria
Prior art keywords
diazacyclopentaca
naphthalinyl
oxa
aminomethyl
tetrahydro
Prior art date
Application number
AT02761135T
Other languages
English (en)
Inventor
Richard Eric Mewshaw
Rulin Zhao
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE338759T1 publication Critical patent/ATE338759T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02761135T 2001-07-20 2002-07-19 2-(aminomethyl)tetrahydro-9-oxa-1,3- diazacyclopentaca)naphthalinylderivate mit antipsychotischer wirkung ATE338759T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30693001P 2001-07-20 2001-07-20

Publications (1)

Publication Number Publication Date
ATE338759T1 true ATE338759T1 (de) 2006-09-15

Family

ID=23187504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02761135T ATE338759T1 (de) 2001-07-20 2002-07-19 2-(aminomethyl)tetrahydro-9-oxa-1,3- diazacyclopentaca)naphthalinylderivate mit antipsychotischer wirkung

Country Status (12)

Country Link
US (1) US6541501B2 (de)
EP (1) EP1409490B1 (de)
JP (1) JP2005501041A (de)
CN (1) CN100369915C (de)
AT (1) ATE338759T1 (de)
BR (1) BR0211340A (de)
CA (1) CA2454545A1 (de)
DE (1) DE60214558T2 (de)
DK (1) DK1409490T3 (de)
ES (1) ES2271320T3 (de)
MX (1) MXPA04000580A (de)
WO (1) WO2003008420A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014030688A1 (ja) * 2012-08-24 2014-02-27 第一三共株式会社 鎖状側鎖を有するクロモン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE4140540A1 (de) 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
US5756532A (en) 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
AR004523A1 (es) 1995-11-06 1998-12-16 American Home Prod 2-(AMINOMETIL)-3,4,7,9-TETRAHIDRO-2H-PIRANO-[2,3e] INDOL-8-ONAS Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
US5750556A (en) 1996-10-30 1998-05-12 American Home Products Corporation 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano- 2,3-E!indol-8-ones and derivatives

Also Published As

Publication number Publication date
WO2003008420A1 (en) 2003-01-30
US6541501B2 (en) 2003-04-01
DE60214558D1 (de) 2006-10-19
US20030037701A1 (en) 2003-02-27
EP1409490A1 (de) 2004-04-21
DE60214558T2 (de) 2007-09-20
EP1409490B1 (de) 2006-09-06
DK1409490T3 (da) 2006-10-30
BR0211340A (pt) 2004-09-28
MXPA04000580A (es) 2004-04-20
ES2271320T3 (es) 2007-04-16
CA2454545A1 (en) 2003-01-30
JP2005501041A (ja) 2005-01-13
CN100369915C (zh) 2008-02-20
CN1555376A (zh) 2004-12-15

Similar Documents

Publication Publication Date Title
EA200600203A1 (ru) Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
NO20040100L (no) Nye forbindelser som anti-inflammasjons, immunmodulerende og anti-proliferative midler
SE9900100D0 (sv) New compounds
MY135841A (en) Novel benzodioxoles
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
NO20062256L (no) Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
ATE417856T1 (de) Motilidverbindungen
ECSP024377A (es) Derivados de benzo (g) quinolina
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
DK1434588T3 (da) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)aminoalkylsyrederivater til behandling af smerte
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
ATE338759T1 (de) 2-(aminomethyl)tetrahydro-9-oxa-1,3- diazacyclopentaca)naphthalinylderivate mit antipsychotischer wirkung
MXPA04002492A (es) Uso novedoso de aminometil cromanos sustituidos.
ATE338046T1 (de) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität
PA8558901A1 (es) Nuevos compuestos hexaciclicos
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
HRP20030653B1 (en) Novel benzoylguanidine salt

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties